|
168例肺腺癌患者靶向治疗联合放化疗与其预后因素分析
|
Abstract:
[1] | Yourdon, D.R., Cramb, S.M. and Baade, P.D. (2008) The International Epidemiology of Lung Cancer: Geographical Distribution and Secular Trends. Journal of Thoracic Oncology, 3, 819-831.
http://dx.doi.org/10.1097/JTO.0b013e31818020eb |
[2] | Brundage, M.D., Davies, D. and Mackillop, W.J. (2002) Prognostic Factors in Non-Small Cell Lung Cancer: A Decade of Progress. Chest, 122, 1037-1057. http://dx.doi.org/10.1378/chest.122.3.1037 |
[3] | Libby, P. (2002) Inflammation in Atherosclerosis. Nature, 420, 868-870. http://dx.doi.org/10.1038/nature01323 |
[4] | Yang, P., Bamlet, W.R., Ebbert, J.O., et al. (2004) Glutathione Pathway Genes and Lung Cancer Risk in Young and Old Populations. Carcinogenesis, 25, 1935-1944. http://dx.doi.org/10.1093/carcin/bgh203 |
[5] | Yazgan, S., Gursoy, S., Yaldiz, S., et al. (2005) Outcome of Surgery for Lung Cancer in Young and Elderly Patients. Surgery Today, 35, 823-827. http://dx.doi.org/10.1007/s00595-004-3035-7 |
[6] | 曹建忠. 局部晚期非小细胞肺癌放疗或化放综合治疗预后因素分析MicroRNA在小细胞肺癌中的预后价值[D]: [博士学位论文]. 北京: 中国协和医科大学, 2009. |
[7] | Minami, H., Yoshimura, M., Matsuoka, H., et al. (2001) Lung Cancer Treated Surgically in Patients < 50 Years of Age. Chest, 120, 32-36. http://dx.doi.org/10.1378/chest.120.1.32 |
[8] | Jubelirer, S.J., Varela, N.L., Welch, C.A., et al. (2009) Does Sex Make a Difference in Survival of Patients Undergoing resection for Early Stage Non-Small Cell Lung Cancer (NSCLC)? West Virginia Medical Journal, 105, 18-22. |
[9] | Moore, R., Doherty, D., Chamberlain, R., et al. (2004) Sex Differences in Survival in Non Small Cell Lung Cancer Patients 1974-1998. Acta Oncologica, 43, 57-64. http://dx.doi.org/10.1080/02841860310017973 |
[10] | 岳东升, 王长利, 张真发, 等. 107例细支气管肺泡癌临床特征及预后分析[J]. 中国肿瘤临床, 2007, 34(9): 515- 518. |
[11] | 黄彬鋆, 肖静, 吴桂云, 等. 214例肺腺癌患者预后因素分析[J]. 中华疾病控制杂志, 2015, 19(8): 806-810. |
[12] | Don, R. and Hill, A.B. (1950) Smoking and Carcinoma of the Lung Preliminary Report. British Medical Journal, 2, 739-748. http://dx.doi.org/10.1136/bmj.2.4682.739 |
[13] | Wakelee, H.A., Chang, E.T., Gomlez, S.L., et al. (2007) Lung Cancer Incidence in Never Smokers. Journal of Clinical Oncology, 25, 472-478. http://dx.doi.org/10.1200/JCO.2006.07.2983 |
[14] | 方美玉, 姜初明, 赵亚珍, 等. 无吸烟史肺癌与吸烟相关肺癌临床比较[J]. 中国呼吸与危重监护杂志, 2010, 9(2): 177-180. |
[15] | Meguid, R.A., Hooker, C.M., Harris, J., et al. (2010) Long-Term Survival Outcomes by smoking Status in Surgical and Nonsurgical Patients with Non-Small Cell Lung Cancer: Comparing Never Smokers and Current Smokers. Chest, 138, 500-509. http://dx.doi.org/10.1378/chest.08-2991 |
[16] | (1995) Chemotherapy in Non-Small Cell Lung Cancer: A Meta-Analysis Using Updated Data on Individual Patients from 52 Randomised Clinical Trials. Non-small Cell Lung Cancer Collaborative Group. British Medical Journal, 311, 899-909. http://dx.doi.org/10.1136/bmj.311.7010.899 |
[17] | Stephens, R.J., Fairlamb, N., Gower, N., et al. (2002) The Big Lung Trial (BLT): Determining the Value of Cisplatin-Based Chemotherapy for all Patients with Non-Small Cell Lung Cancer (NSCLC). Preliminary Results in the Supportive Care Setting. Proceedings of the Annual Meeting of the American Society of Clinical Oncology, 21, 1161. |
[18] | 王彩. 319例晚期肺腺癌患者临床预后因素分析[D]: [硕士学位论文]. 河北: 河北医科大学, 2014. |
[19] | O’Rourke, N., Roqu, I., Figuls, M., et al. (2010) Concurrent Chemoradiotherapy in Non-Small Cell Lung Cancer. Cochrane Database of Systematic Reviews, 16, 140-146. http://dx.doi.org/10.1002/14651858.cd002140.pub3 |
[20] | 杨俊体. 姑息性放疗对IV期非小细胞肺癌预后及生存质量的影响[D]: [硕士学位论文]. 山西: 山西医科大学, 2012. |
[21] | Nagata, Y., Oro, Y., Aoki, T., et al. (2002) Clinical Outcomes of 3D Conformal Hypofractionated Single High-Dose Radiotherapy for One or Two Lung Tumors Using a Stereotactic Body Frame. International Journal of Radiation Oncology * Biology * Physics, 52, 1041-1043. http://dx.doi.org/10.1016/S0360-3016(01)02731-6 |
[22] | Huang, S.F., Liu, H.P., Li, L.H., et al. (2004) High Frequency of Epidermal Growth Factor Receptor Mutations with Complex Patterns in Non-Small Cell Lung Cancers Related to Gefitinib Responsiveness in Taiwan. Clinical Cancer Research, 10, 8195-8203. http://dx.doi.org/10.1158/1078-0432.CCR-04-1245 |
[23] | Mok, T.S., Wu, Y.L., Thongprasert, S., et al. (2009) Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma. The New England Journal of Medicine, 361, 947-957. http://dx.doi.org/10.1056/NEJMoa0810699 |
[24] | Jenab-Wolcott, J. and Giantonio, B.J. (2009) Bevacizumab: Current Indicationgs and Future Development for Management of Solid Tumors. Expert Opinion Biological Therapy, 9, 507-517.
http://dx.doi.org/10.1517/14712590902817817 |
[25] | 王竞, 夏廷毅, 王颖杰等. 靶向药物同步个体化放疗晚期/转移性非小细胞肺癌的Ⅱ期临床试验[J]. 癌症进展. 2011, 1(9): 94-101. |